Unnati Pharmax

Careprost Eye Drops
Composition: Bimatoprost Ophthalmic Solution
International Trade Name: Latisse®, Lumigan®

Careprost is a high-quality Bimatoprost ophthalmic solution, a prostaglandin analog indicated for the management of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Manufactured in WHO-GMP certified facilities, Careprost Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and vision health programs.

Bimatoprost works by increasing the outflow of aqueous humor through the uveoscleral and trabecular meshwork pathways, thereby effectively reducing intraocular pressure. This sustained IOP-lowering effect helps protect the optic nerve from progressive damage and reduces the risk of glaucoma-related vision loss. Additionally, Bimatoprost is known for promoting eyelash growth, making it widely used in both therapeutic and cosmetic ophthalmology.

Careprost Eye Drops are primarily indicated for the treatment of open-angle glaucoma and ocular hypertension. They are suitable for adult patients under medical supervision and may be used as monotherapy or in combination with other IOP-lowering medications.

Careprost Bimatoprost Ophthalmic Eye Drops are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, ophthalmology clinics, retail pharmacies, and international pharmaceutical distributors.

Timolet Eye Drops
Composition: Timolol Maleate Ophthalmic Solution
International Trade Name: Timoptic®

Timolet Eye Drops is a high-quality Timolol Maleate ophthalmic formulation, a non-selective beta-adrenergic blocker used for the effective management of elevated intraocular pressure. Manufactured in WHO-GMP certified facilities, Timolet Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and glaucoma management programs.

Timolol works by reducing the production of aqueous humor in the eye, thereby lowering intraocular pressure. This helps prevent damage to the optic nerve and reduces the risk of vision loss in patients with glaucoma and ocular hypertension. Timolet Eye Drops provide sustained pressure control with good tolerability when used as prescribed.

Timolet Eye Drops are primarily indicated for the treatment of open-angle glaucoma, ocular hypertension, and other conditions associated with increased intraocular pressure. It is suitable for adult patients under strict medical supervision, and may be used as monotherapy or in combination with other anti-glaucoma medications.

Timolet Timolol Maleate Eye Drops are manufactured under stringent GMP and ophthalmic-grade quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in sterile, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, eye clinics, retail pharmacies, and international pharmaceutical distributors.

Hynidase Injection
Composition: Hyaluronidase Injection
International Trade Name: Hylenex®, Vitrase®

Hynidase is a high-quality Hyaluronidase injection, an enzyme preparation used to enhance the dispersion and absorption of injected drugs and fluids in subcutaneous and intramuscular tissues. Manufactured in WHO-GMP certified facilities, Hynidase Injection is supplied by trusted pharmaceutical exporters from India to support global surgical, anesthetic, and emergency care programs.

Hyaluronidase works by temporarily breaking down hyaluronic acid in connective tissues, increasing tissue permeability and promoting faster diffusion of injected solutions. This action facilitates improved drug absorption, reduces localized edema, and enhances the effectiveness of various injectable therapies.

Hynidase Injection is primarily indicated as an adjuvant to increase the absorption and dispersion of other injected medications, for hypodermoclysis, subcutaneous fluid administration, and in the management of extravasation. It is suitable for adult and pediatric patients under strict medical supervision in hospital and clinical settings.

Hynidase Hyaluronidase Injection is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The injection is supplied in secure, tamper-proof, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, surgical centers, emergency units, aesthetic clinics, and international pharmaceutical distributors.

Alphagan Eye Drops
Composition: Brimonidine Tartrate Ophthalmic Solution 0.15%
International Trade Name: Alphagan®

Alphagan is a high-quality Brimonidine Tartrate 0.15% ophthalmic solution, an alpha-2 adrenergic agonist used for the management of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Manufactured in WHO-GMP certified facilities, Alphagan Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and vision health programs.

Brimonidine Tartrate works by reducing aqueous humor production and increasing uveoscleral outflow, thereby effectively lowering intraocular pressure. This dual mechanism helps protect the optic nerve from damage and slows the progression of glaucoma-related vision loss, while maintaining a favorable ocular safety profile.

Alphagan Eye Drops are primarily indicated for the treatment of open-angle glaucoma and ocular hypertension. They are suitable for adult and pediatric patients under medical supervision, either as monotherapy or in combination with other intraocular pressure–lowering agents.

Alphagan Brimonidine Tartrate Eye Drops 0.15% are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, ophthalmology clinics, retail pharmacies, and international pharmaceutical distributors.

Alphagan Eye Drops
Composition: Brimonidine Tartrate Ophthalmic Solution 0.1%
International Trade Name: Alphagan®

Alphagan is a high-quality Brimonidine Tartrate 0.1% ophthalmic solution, a selective alpha-2 adrenergic receptor agonist used for the effective management of elevated intraocular pressure. Manufactured in WHO-GMP certified facilities, Alphagan Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and glaucoma treatment programs.

Brimonidine works by reducing aqueous humor production and increasing uveoscleral outflow, thereby lowering intraocular pressure. This dual mechanism helps protect the optic nerve from damage and reduces the risk of progressive vision loss in patients with glaucoma and ocular hypertension. Alphagan provides sustained pressure control with good tolerability when used as prescribed.

Alphagan Eye Drops are primarily indicated for the treatment of open-angle glaucoma and ocular hypertension. It is suitable for adult patients under strict medical supervision and may be used as monotherapy or in combination with other intraocular pressure-lowering agents.

Alphagan Brimonidine Tartrate Eye Drops 0.1% are manufactured under stringent GMP and ophthalmic-grade quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in sterile, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, eye clinics, retail pharmacies, and international pharmaceutical distributors.

Alphagan Eye Drops
Composition: Brimonidine Tartrate Ophthalmic Solution 0.2%
International Trade Name: Alphagan®

Alphagan is a high-quality Brimonidine Tartrate 0.2% ophthalmic solution, an alpha-2 adrenergic agonist used for the management of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Manufactured in WHO-GMP certified facilities, Alphagan Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and vision health programs.

Brimonidine Tartrate works by reducing the production of aqueous humor and increasing uveoscleral outflow, thereby effectively lowering intraocular pressure. This dual mechanism helps protect the optic nerve from progressive damage and reduces the risk of vision loss associated with glaucoma, while maintaining a favorable ocular safety profile.

Alphagan Eye Drops 0.2% are primarily indicated for the treatment of open-angle glaucoma and ocular hypertension. They are suitable for adult and pediatric patients under medical supervision, either as monotherapy or in combination with other intraocular pressure–lowering agents.

Alphagan Brimonidine Tartrate Eye Drops 0.2% are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, ophthalmology clinics, retail pharmacies, and international pharmaceutical distributors.

FML-T Ophthalmic Suspension
Composition: Tobramycin 0.3% & Fluorometholone Acetate 0.1% Ophthalmic Suspension
International Trade Name: FML-T®

FML-T is a high-quality combination ophthalmic suspension containing Tobramycin, a broad-spectrum antibiotic, and Fluorometholone Acetate, a corticosteroid, formulated for the management of inflammatory and bacterial eye conditions. Manufactured in WHO-GMP certified facilities, FML-T Ophthalmic Suspension is supplied by trusted pharmaceutical exporters from India to support global ophthalmic care programs.

Tobramycin works by inhibiting bacterial protein synthesis, effectively treating Gram-positive and Gram-negative bacterial infections of the eye. Fluorometholone Acetate reduces ocular inflammation, redness, and swelling by suppressing the immune-mediated inflammatory response. The combination provides rapid relief while controlling infection and preventing tissue damage.

FML-T Ophthalmic Suspension is primarily indicated for the treatment of bacterial conjunctivitis, keratitis, and other ocular inflammatory conditions where corticosteroid therapy is needed alongside antibacterial coverage. It is suitable for adult and pediatric patients under strict medical supervision.

FML-T Tobramycin & Fluorometholone Acetate Ophthalmic Suspension is manufactured under stringent GMP and ophthalmic-grade quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The suspension is supplied in sterile, tamper-proof, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, eye clinics, retail pharmacies, and international pharmaceutical distributors.

FML Eye Drops
Composition: Fluorometholone Ophthalmic Suspension
International Trade Name: FML®

FML is a high-quality Fluorometholone ophthalmic suspension, a corticosteroid indicated for the treatment of steroid-responsive inflammatory conditions of the eye. Manufactured in WHO-GMP certified facilities, FML Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and vision health programs.

Fluorometholone works by inhibiting inflammatory mediators, reducing redness, swelling, itching, and discomfort associated with ocular inflammation. Its targeted anti-inflammatory action helps relieve symptoms while minimizing the risk of increased intraocular pressure when used as directed under medical supervision.

FML Eye Drops are primarily indicated for the treatment of ocular inflammation associated with allergic conjunctivitis, uveitis, keratitis, post-operative inflammation, and other steroid-responsive eye conditions. They are suitable for adult and pediatric patients under ophthalmologist supervision.

FML Fluorometholone Eye Drops are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, ophthalmology clinics, retail pharmacies, and international pharmaceutical distributors.

Prednisolone Ophthalmic Eye Drops
Composition: Prednisolone Sodium Phosphate / Prednisolone Acetate Eye Drops
International Trade Name: Pred Forte®, Econopred®

Prednisolone Ophthalmic Eye Drops is a high-quality corticosteroid formulation designed for the effective management of inflammatory conditions of the eye. Manufactured in WHO-GMP certified facilities, Prednisolone Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and treatment programs.

Prednisolone is a potent anti-inflammatory corticosteroid that works by suppressing inflammatory responses, reducing redness, swelling, itching, and discomfort in ocular tissues. It inhibits the release of inflammatory mediators, providing rapid and sustained relief in various inflammatory and allergic eye conditions while maintaining a favorable safety profile when used as prescribed.

Prednisolone Ophthalmic Eye Drops are primarily indicated for the treatment of allergic conjunctivitis, uveitis, iritis, keratitis, postoperative ocular inflammation, and other steroid-responsive inflammatory eye disorders. It is suitable for adult and pediatric patients under strict medical supervision.

Prednisolone Ophthalmic Eye Drops are manufactured under stringent GMP and ophthalmic-grade quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in sterile, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, eye clinics, retail pharmacies, and international pharmaceutical distributors.

Amplinak Eye Drops
Composition: Nepafenac Ophthalmic Suspension 1mg
International Trade Name: Nevanac®

Amplinak is a high-quality Nepafenac ophthalmic suspension, a non-steroidal anti-inflammatory drug (NSAID) formulated for the effective management of ocular pain and inflammation. Manufactured in WHO-GMP certified facilities, Amplinak Eye Drops are supplied by trusted pharmaceutical exporters from India to support global ophthalmic care and post-surgical treatment programs.

Nepafenac is a prodrug that penetrates the cornea and is converted into amfenac, a potent inhibitor of cyclooxygenase (COX) enzymes. This mechanism reduces the synthesis of inflammatory prostaglandins, thereby relieving pain, swelling, and redness associated with ocular inflammation. Amplinak provides targeted and sustained anti-inflammatory action with excellent ocular tolerability.

Amplinak Ophthalmic Suspension is primarily indicated for the treatment and prevention of pain and inflammation associated with cataract surgery and other ocular surgical procedures. It is suitable for adult patients under strict medical supervision and may be used as part of a comprehensive postoperative care regimen.

Amplinak Nepafenac Ophthalmic Suspension is manufactured under stringent GMP and ophthalmic-grade quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The drops are supplied in sterile, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, eye clinics, retail pharmacies, and international pharmaceutical distributors.

Virataz R Tablets
Composition: Atazanavir 300mg & Ritonavir 100mg Tablets
International Trade Name: Reyataz® + Norvir®

Virataz R is a high-quality fixed-dose combination of Atazanavir and Ritonavir tablets, used as part of antiretroviral therapy (ART) for the management of HIV-1 infection. Manufactured in WHO-GMP certified facilities, Virataz R Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment and prevention programs.

Atazanavir is a protease inhibitor that prevents the cleavage of viral polyproteins, thereby inhibiting the production of mature infectious HIV particles. Ritonavir acts as a pharmacokinetic booster by inhibiting the metabolism of Atazanavir, increasing its plasma concentration and enhancing its therapeutic effectiveness. This combination ensures sustained viral suppression and improved treatment outcomes.

Virataz R Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents. They are suitable for adult patients under strict medical supervision as part of a comprehensive HIV management regimen.

Virataz R Atazanavir & Ritonavir Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, ART centers, government healthcare programs, NGOs, and international pharmaceutical distributors.